If you don't already know about them, software-as-a-service (SaaS) stocks are worth researching. Companies that develop truly helpful software benefit from a slate of advantages: reliable and recurring revenue, moderately high switching costs to lock customers in, the ability to develop new tools based on data gathered, and the fact that it's virtually free to grant access to software.
Today, we'll be investigating two leaders in this realm. Zendesk focuses on software solutions to help companies track their interactions with customers. Veeva Systems has developed a suite of solutions to help drug companies bring their products through trials and to the market.
But between the two, which is the better buy today?